Patent · US Active

Tumor treatment methods using cells that localize to the tumor

US11541119B2 · kind B2 · utility

0Cited by
3References
13Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 22, 2019
Grant dateJan 3, 2023
Priority date
Expiry dateFeb 7, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/88
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and composition for cell-based therapy as well as somatostatin receptor-based therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a signaling defective somatostatin receptor mutant are described. Furthermore, the invention provides compositions and methods involve a somatostatin constitutively active somatostatin receptor mutant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.